Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss National Bank decreased its position in shares of Nevro Corp. (NYSE:NVRO – Free Report) by 10.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 72,600 shares of the medical equipment provider’s stock after selling 8,500 shares during the period. Swiss National […]
Artivion (NYSE:AORT – Get Free Report) and Nevro (NYSE:NVRO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends. Profitability This table compares Artivion and Nevro’s net margins, […]
Biostage (OTCMKTS:BSTG – Get Free Report) and Nevro (NYSE:NVRO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Institutional and Insider Ownership 90.5% of Nevro shares are […]
Nevro (NYSE:NVRO – Free Report) had its price target reduced by Citigroup from $24.00 to $21.00 in a research report report published on Monday morning, Marketbeat.com reports. They currently have a neutral rating on the medical equipment provider’s stock. A number of other brokerages have also recently issued reports on NVRO. Truist Financial lowered their […]
Royal Bank of Canada reissued their outperform rating on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Thursday morning, Benzinga reports. Royal Bank of Canada currently has a $33.00 target price on the medical equipment provider’s stock. A number of other equities research analysts have also recently commented on NVRO. StockNews.com […]